Treatment of pain with JNK inhibitors

Details for Australian Patent Application No. 2003284980 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.; Faleck, Herbert; Manning, Donald C.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003284980

PCT Number PCT/US2003/0340

PCT Pub. Number WO2004/039325

Priority 60/421,104 24.10.02 US; 10/693,793 23.10.03 US

Filing date 24 October 2003

Wipo publication date 25 May 2004

Acceptance publication date 7 August 2008

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/421,104 24.10.02 US; 10/693,793 23.10.03 US

24 June 2004 Application Open to Public Inspection

  Published as AU-B-2003284980

7 August 2008 Application Accepted

  Published as AU-B-2003284980

4 December 2008 Standard Patent Sealed

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003284981-Inhibitors of Akt activity

2003284979-Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain